CRISPR/Cas9-Mediated Genome Editing to Generate Clonal iPSC Lines
The ability to reprogram somatic cells into induced pluripotent stem cells (iPSCs) was developed in 2006 and represented a major breakthrough in stem cell research. A more recent milestone in biomedical research was reached in 2013 when the CRISPR/Cas9 system was used to edit the genome of mammalian...
Saved in:
Published in | Methods in molecular biology (Clifton, N.J.) |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
24.03.2021
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | The ability to reprogram somatic cells into induced pluripotent stem cells (iPSCs) was developed in 2006 and represented a major breakthrough in stem cell research. A more recent milestone in biomedical research was reached in 2013 when the CRISPR/Cas9 system was used to edit the genome of mammalian cells. The coupling of both human (h)iPSCs and CRISPR/Cas9 technology offers great promise for cell therapy and regenerative medicine. However, several limitations including time and labor consumption, efficiency and efficacy of the system, and the potential off-targets effects induced by the Cas9 nuclease still need to be addressed. Here, we describe a detailed method for easily engineering genetic changes in hiPSCs, using a nucleofection-mediated protocol to deliver the CRISPR/Cas9 components into the cells, and discuss key points to be considered when designing your experiment. The clonal, genome-edited hiPSC line generated via our method can be directly used for downstream applications. |
---|---|
AbstractList | The ability to reprogram somatic cells into induced pluripotent stem cells (iPSCs) was developed in 2006 and represented a major breakthrough in stem cell research. A more recent milestone in biomedical research was reached in 2013 when the CRISPR/Cas9 system was used to edit the genome of mammalian cells. The coupling of both human (h)iPSCs and CRISPR/Cas9 technology offers great promise for cell therapy and regenerative medicine. However, several limitations including time and labor consumption, efficiency and efficacy of the system, and the potential off-targets effects induced by the Cas9 nuclease still need to be addressed. Here, we describe a detailed method for easily engineering genetic changes in hiPSCs, using a nucleofection-mediated protocol to deliver the CRISPR/Cas9 components into the cells, and discuss key points to be considered when designing your experiment. The clonal, genome-edited hiPSC line generated via our method can be directly used for downstream applications. |
Author | Sanjurjo-Soriano, Carla Kalatzis, Vasiliki Erkilic, Nejla Mamaeva, Daria |
Author_xml | – sequence: 1 givenname: Carla surname: Sanjurjo-Soriano fullname: Sanjurjo-Soriano, Carla organization: University of Montpellier, Montpellier, France – sequence: 2 givenname: Nejla surname: Erkilic fullname: Erkilic, Nejla organization: University of Montpellier, Montpellier, France – sequence: 3 givenname: Daria surname: Mamaeva fullname: Mamaeva, Daria organization: University of Montpellier, Montpellier, France – sequence: 4 givenname: Vasiliki surname: Kalatzis fullname: Kalatzis, Vasiliki email: vasiliki.kalatzis@inserm.fr, vasiliki.kalatzis@inserm.fr organization: University of Montpellier, Montpellier, France. vasiliki.kalatzis@inserm.fr |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33755901$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j11LwzAYhYMo7kMvvZX8gbo3b5KmvRxhzkHFsel1yVcl0qajrRf-eyfq1YHzwHk4C3KZ-hQIuWPwwADUSuWS1QjIap7jBZmzUkCWA5YzshjHDwChOIprMuNcSVkCm5O1PuyO-8NKm7HMnoOPZgqebkPqu0A3Pk4xvdOp_2nCcGZUt30yLY37o6ZVTGG8IVeNacdw-5dL8va4edVPWfWy3el1lTl2tmbOeGsFSMGVFapwTJqce9kwyVVwsrFBFoVrFKhCWodSKCwZCOccqgId4JLc_-6ePm0XfH0aYmeGr_r_C34Dc7ZIOg |
CitedBy_id | crossref_primary_10_1172_JCI167953 |
ContentType | Journal Article |
DBID | NPM |
DOI | 10.1007/7651_2021_362 |
DatabaseName | PubMed |
DatabaseTitle | PubMed |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1940-6029 |
ExternalDocumentID | 33755901 |
Genre | Journal Article |
GroupedDBID | --- 29M 53G ACGFS ALMA_UNASSIGNED_HOLDINGS F5P NPM P2P RSU SPO UDS WH7 ZGI |
ID | FETCH-LOGICAL-c1732-cadbb405437b478c15a63d5f1537ec5fbe588cf70785bc254729104ccc2782c02 |
IngestDate | Fri May 24 00:20:06 EDT 2024 |
IsPeerReviewed | false |
IsScholarly | true |
Keywords | Single-cell sorting iPSCs Genome editing CRISPR/Cas9 Nucleofection |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1732-cadbb405437b478c15a63d5f1537ec5fbe588cf70785bc254729104ccc2782c02 |
PMID | 33755901 |
ParticipantIDs | pubmed_primary_33755901 |
PublicationCentury | 2000 |
PublicationDate | 20210324 |
PublicationDateYYYYMMDD | 2021-03-24 |
PublicationDate_xml | – month: 03 year: 2021 text: 20210324 day: 24 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Methods in molecular biology (Clifton, N.J.) |
PublicationTitleAlternate | Methods Mol Biol |
PublicationYear | 2021 |
SSID | ssj0047324 |
Score | 2.36284 |
Snippet | The ability to reprogram somatic cells into induced pluripotent stem cells (iPSCs) was developed in 2006 and represented a major breakthrough in stem cell... |
SourceID | pubmed |
SourceType | Index Database |
Title | CRISPR/Cas9-Mediated Genome Editing to Generate Clonal iPSC Lines |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33755901 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBbrxkpfxtb1ugt62FtQ6shW5DyWkK0rJJSmhb4FSZbAaWKXxhs0v75HOnaTdiu7vBgjISP5-3x8jnQuhHzhmRTKyh4TUZSxJHGCgR6nWZplyvJIGhFiq4aj7sllcnolrlZuYyG6pNJts_xtXMn_oAptgKuPkv0HZB8eCg1wD_jCFRCG619h3D__Pj479ylu1aLHhqHqBiiQ32xRzm1rkOVYBaKsk0tXttWfhZ2__GwczPHagbCp6BSqSQcH2XlTNbfVZGnC015XNQFap-21TYSxKqY_bqclG5ew7KKsXUlmDzJ_cHudz_JQTX1kp6v2oZor-xPPnBR6PKP8VzNVLetS7WoBY6_z9Q0KHjy0MC66bVGo9nyIQYST-kVko5eG7IrOxI-exCid1-C7mQf84lgKHyn7594nGbSbrg2yIVMvC0d-Rwf_1okEjbLOvepDKh_NY4tsNmOfWB1B-7h4S97UZgM9Rg68Iy9ssU1eYyHRu_fkGJlw9IgHFHlAax7QqqQNDyjygHoe0MCDHXL5dXDRP2F1cQxmOjBnZlSmNWjbSSx1IlPTEaobZ8LBH0xaI5y2Ik2N88mchDZcJGBFgeltjOGgFJqI75KXRVnYfUK1M1GiQBXN_KGscUpwaRV3oqtT2-HmgOzh2ic3mAFl0ryVw2d7PpCtFRc-klcOPjn7CfS3Sn8OANwDRe8_gQ |
link.rule.ids | 783 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CRISPR%2FCas9-Mediated+Genome+Editing+to+Generate+Clonal+iPSC+Lines&rft.jtitle=Methods+in+molecular+biology+%28Clifton%2C+N.J.%29&rft.au=Sanjurjo-Soriano%2C+Carla&rft.au=Erkilic%2C+Nejla&rft.au=Mamaeva%2C+Daria&rft.au=Kalatzis%2C+Vasiliki&rft.date=2021-03-24&rft.eissn=1940-6029&rft_id=info:doi/10.1007%2F7651_2021_362&rft_id=info%3Apmid%2F33755901&rft_id=info%3Apmid%2F33755901&rft.externalDocID=33755901 |